Home NDC 50090-2129 Lamotrigine
Product NDC 50090-2129
11-digit product format 500902129
Labeler code 50090
Product ID 50090-2129_36f4048a-f5fd-42dc-8a01-6078b47f624f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lamotrigine
Dosage form TABLET
Route ORAL
Labeler A-S Medication Solutions
Application ANDA090170
Marketing category ANDA
Marketing start 2011-11-01
Substance LAMOTRIGINE
Active strength 25 mg/1
Pharmacologic classes Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090170-001 LAMOTRIGINE LAMOTRIGINE 25MG TABLET / ORAL AB 2011-10-06 A090170-002 LAMOTRIGINE LAMOTRIGINE 100MG TABLET / ORAL AB 2011-10-06 A090170-003 LAMOTRIGINE LAMOTRIGINE 150MG TABLET / ORAL AB 2011-10-06 A090170-004 LAMOTRIGINE LAMOTRIGINE 200MG TABLET / ORAL AB 2011-10-06
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A090170-001 LAMOTRIGINE 25MG TABLET / ORAL AB 2011-10-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 A090170-002 LAMOTRIGINE 100MG TABLET / ORAL AB 2011-10-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 A090170-003 LAMOTRIGINE 150MG TABLET / ORAL AB 2011-10-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 A090170-004 LAMOTRIGINE 200MG TABLET / ORAL AB 2011-10-06 84e616aacf4f…2026-08-18 06:07:40 2026-07 A090170-001 LAMOTRIGINE 25MG TABLET / ORAL AB 2011-10-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A090170-002 LAMOTRIGINE 100MG TABLET / ORAL AB 2011-10-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A090170-003 LAMOTRIGINE 150MG TABLET / ORAL AB 2011-10-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A090170-004 LAMOTRIGINE 200MG TABLET / ORAL AB 2011-10-06 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A090170-001 LAMOTRIGINE 25MG TABLET / ORAL AB 2011-10-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090170-002 LAMOTRIGINE 100MG TABLET / ORAL AB 2011-10-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090170-003 LAMOTRIGINE 150MG TABLET / ORAL AB 2011-10-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090170-004 LAMOTRIGINE 200MG TABLET / ORAL AB 2011-10-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090170-001 LAMOTRIGINE 25MG TABLET / ORAL AB 2011-10-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090170-002 LAMOTRIGINE 100MG TABLET / ORAL AB 2011-10-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090170-003 LAMOTRIGINE 150MG TABLET / ORAL AB 2011-10-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090170-004 LAMOTRIGINE 200MG TABLET / ORAL AB 2011-10-06 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A090170-001 LAMOTRIGINE 25MG TABLET / ORAL AB 2011-10-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090170-002 LAMOTRIGINE 100MG TABLET / ORAL AB 2011-10-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090170-003 LAMOTRIGINE 150MG TABLET / ORAL AB 2011-10-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090170-004 LAMOTRIGINE 200MG TABLET / ORAL AB 2011-10-06 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090170-001 LAMOTRIGINE 25MG TABLET / ORAL AB 2011-10-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090170-002 LAMOTRIGINE 100MG TABLET / ORAL AB 2011-10-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090170-003 LAMOTRIGINE 150MG TABLET / ORAL AB 2011-10-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090170-004 LAMOTRIGINE 200MG TABLET / ORAL AB 2011-10-06 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090170-001 LAMOTRIGINE 25MG TABLET / ORAL AB 2011-10-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090170-002 LAMOTRIGINE 100MG TABLET / ORAL AB 2011-10-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090170-003 LAMOTRIGINE 150MG TABLET / ORAL AB 2011-10-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090170-004 LAMOTRIGINE 200MG TABLET / ORAL AB 2011-10-06 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090170-001 LAMOTRIGINE 25MG TABLET / ORAL AB 2011-10-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090170-002 LAMOTRIGINE 100MG TABLET / ORAL AB 2011-10-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090170-003 LAMOTRIGINE 150MG TABLET / ORAL AB 2011-10-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090170-004 LAMOTRIGINE 200MG TABLET / ORAL AB 2011-10-06 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090170-001 LAMOTRIGINE 25MG TABLET / ORAL AB 2011-10-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090170-002 LAMOTRIGINE 100MG TABLET / ORAL AB 2011-10-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090170-003 LAMOTRIGINE 150MG TABLET / ORAL AB 2011-10-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090170-004 LAMOTRIGINE 200MG TABLET / ORAL AB 2011-10-06 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090170-001 LAMOTRIGINE 25MG TABLET / ORAL AB 2011-10-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090170-002 LAMOTRIGINE 100MG TABLET / ORAL AB 2011-10-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090170-003 LAMOTRIGINE 150MG TABLET / ORAL AB 2011-10-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090170-004 LAMOTRIGINE 200MG TABLET / ORAL AB 2011-10-06 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 172 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Lamotrigine
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LAMOTRIGINE 25 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination U3H27498KS Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 198427 Internal RxNorm lookup 198428 Internal RxNorm lookup 282401 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 50090-2129-0 2023-02-07 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 50090-2129-0 2023-02-07 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 50090-2129-1 2023-02-07 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 50090-2129-1 2023-02-07 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 50090-2129-2 2023-02-07 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 50090-2129-2 2023-02-07 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 50090-2129-0 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 50090-2129-0 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 50090-2129-1 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 50090-2129-1 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 50090-2129-2 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 50090-2129-2 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50090-2129-0 Lamotrigine 60 in 1 BOTTLE TABLET 60 28 50090-2129-1 Lamotrigine 180 in 1 BOTTLE TABLET 180 28 50090-2129-2 Lamotrigine 30 in 1 BOTTLE TABLET 30 28
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50090-2129 LAMOTRIGINE TABLET [A-S MEDICATION SOLUTIONS] 25 Current NDC, Legacy NDC, 3 package rows 20240824_6139a858-700c-4eb9-9f84-99d280bde326.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 24 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Lamotrigine LAMOTRIGINE Proficient Rx LP 6f7e59d2-4311-42a0-93a0-b29b0417d96f 2024-02-01 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090170 application number: ANDA090170 Lamotrigine LAMOTRIGINE Proficient Rx LP 52273d60-3f27-4846-bf40-014ebcf09417 2022-05-02 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090170 application number: ANDA090170 Lamotrigine LAMOTRIGINE Proficient Rx LP b94ae2e4-e276-40c1-bc25-da980194fc99 2022-04-01 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090170 application number: ANDA090170 Lamotrigine LAMOTRIGINE Asclemed USA, Inc. 8ac9dc83-edb2-4ae5-8064-40f113fd3aab 2020-10-14 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090170 application number: ANDA090170
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50090-2129-0 50090212900 60 TABLET in 1 BOTTLE (50090-2129-0) 60 tablet 2015-10-15 0000-00-00 No No Current 50090-2129-1 50090212901 180 TABLET in 1 BOTTLE (50090-2129-1) 180 tablet 2019-09-25 0000-00-00 No No Current 50090-2129-2 50090212902 30 TABLET in 1 BOTTLE (50090-2129-2) 30 tablet 2020-01-22 0000-00-00 No No Current